Table 1 The clinico-pathological characteristics of patients with primary operable invasive ductal breast cancer (n = 384)
Clinico-pathological characteristics | Patients (n) |
|---|---|
Age (≤50/>50 years) | 107 (28%)/277 (72%) |
Size (≤20/21-50/≥50 mm) | 218 (57%)/154 (40%)/11 (3%) |
Grade (I/II/III) | 70 (18%)/157 (41%)/157 (41%) |
Involved lymph node (0/1-3/>3) | 205 (53%)/108 (28%)/66 (17%) |
Oestrogen -receptor status (ER-/ER+) | 124 (32%)/237 (62%) |
Progesterone -receptor status (PR-/PR+) | 193 (50%)/170 (44%) |
HER-2 status (HER-2 -/HER-2+) | 299 (78%)/65 (17%) |
Ki-67 status (Low Ki-67/High Ki-67) | 272 (71%)/92 (24%) |
LVI (Absent/Present) | 234 (61%)/150 (39%) |
MVD (CD34+) (tertiles 1, 2, 3) | 137 (36%)/126 (33%)/106 (28%) |
Loco-regional treatment (Lumpectomy + radiotherapy/mastectomy + radiotherapy) | 142 (37%)/242 (63%) |
Systemic treatment (ER-based treatment) (hormonal/hormonal + chemotherapy/chemotherapy/none) | 192 (50%)/86 (22%)/80 (21%)/22 (6%) |